FdaApplication
ANDA 207612
Identifiers
- fda_app_no: ANDA207612
Properties
| Property | Value |
|---|---|
| applicant_name | NOVELGENIX THERAPEUTICS PVT LTD |
| application_type | ANDA |
| approval_date | 2018-11-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPROXEN SODIUM | NAPROXEN SODIUM | 220MG | TABLET;ORAL |
1 product